Functional modulation of AMP-activated protein kinase by cereblon

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 3, 2011, Pages 448-455

  Lee, Kwang Min ^a   Jo, Sooyeon ^a   Kim, Hyunyoung ^a   Lee, Jongwon ^a   Park, Chul Seung ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

AMP activated protein kinase 1; Autosomal recessive nonsyndromic mental retardation; Binding protein; Cereblon

Indexed keywords

BINDING PROTEIN; CEREBLON PTOTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA 1 PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL STRAIN; CELL STRAIN HEK293; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CARRIER PROTEINS; CELL LINE; DNA, COMPLEMENTARY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; MICE; NERVE TISSUE PROTEINS; PEPTIDE HYDROLASES; PROTEIN BINDING; RATS;

EID: 79551581810     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.005     Document Type: Article

References (45)

1. Higgins J.J., Pucilowska J., Lombardi R.Q., Rooney J.P. A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 2004, 63:1927-1931.
2. Jo S., Lee K.-H., Song S., Jung Y.-K., Park C.-S. Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain. J. Neurochem. 2005, 1212-1224.
3. Hohberger B., Enz R. Cereblon is expressed in the retina and binds to voltage-gated chloride channels. FEBS Lett. 2009, 583:633-637.
4. Ito T., Ando H., Suzuki T., Ogura T., Hotta K., Imamura Y., Yamaguchi Y., Handa H. Identification of a primary target of thalidomide teratogenicity. Science 2010, 327:1345-1350.
5. Steinberg G.R., Kemp B.E. AMPK in Health and Disease. Physiol. Rev. 2009, 89:1025-1078.
6. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci. 2004, 29:18-24.
7. Dyck J.R., Gao G., Widmer J., Stapleton D., Fernandez C.S., Kemp B.E., Witters L.A. Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J. Biol. Chem. 1996, 271:17798-17803.
8. Oakhill J.S., Scott J.W., Kemp B.E. Structure and function of AMP-activated protein kinase. Acta Physiol. Oxf. 2009, 196:3-14.
9. Xiao B., Heath R., Saiu P., Leiper F.C., Leone P., Jing C., Walker P.A., Haire L., Eccleston J.F., Davis C.T., Martin S.R., Carling D., Gamblin S.J. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 2007, 449:496-500.
10. Hardie D.G., Hawley S.A. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001, 23:1112-1119.
11. Hardie D.G., Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell?. Eur. J. Biochem. 1997, 246:259-273.
12. Mitchelhill K.I., Michell B.J., House C.M., Stapleton D., Dyck J., Gamble J., Ullrich C., Witters L.A., Kemp B.E. Posttranslational Modifications of the 5'-AMP-activated Protein Kinase beta 1 Subunit. J. Biol. Chem. 1997, 272:24475-24479.
13. Warden S.M., Richardson C., O'Donnell J., Stapleton D., Kemp B.E., Witters L.A. Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem. J. 2001, 354:275-283.
14. Polekhina G., Gupta A., Michell B.J., van Denderen B., Murthy S., Feil S.C., Jennings I.G., Campbell D.J., Witters L.A., Parker M.W., Kemp B.E., Stapleton D. AMPK [beta] subunit targets metabolic stress sensing to glycogen. Curr. Biol. 2003, 13:867-871.
15. Townley R., Shapiro L. Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase. Science 2007, 315:1726-1729.
16. Amodeo G.A., Rudolph M.J., Tong L. Crystal structure of the heterotrimer core of Saccharomyces cerevisiae AMPK homologue SNF1. Nature 2007, 449:492-495.
17. Fryer L.G., Parbu-Patel A., Carling D. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002, 277:25226-25232.
18. Hawley S.A., Gadalla A.E., Olsen G.S., Hardie D.G. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 2002, 51:2420-2425.
19. Sambandam N., Lopaschuk G.D. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog. Lipid Res. 2003, 42:238-256.
20. Tian R., Musi N., D'Agostino J., Hirshman M.F., Goodyear L.J. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001, 104:1664-1669.
21. Tokunaga C., Yoshino K., Yonezawa K. mTOR integrates amino acid- and energy-sensing pathways. Biochem. Biophys. Res. Commun. 2004, 313:443-446.
22. Xing Y., Musi N., Fujii N., Zou L., Luptak I., Hirshman M.F., Goodyear L.J., Tian R. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J. Biol. Chem. 2003, 278:28372-28377.
23. Chang S., De Camilli P. Glutamate regulates actin-based motility in axonal filopodia. Nat. Neurosci. 2001, 4:787-793.
24. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G.D., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13:2004-2008.
25. Hurley R.L., Anderson K.A., Franzone J.M., Kemp B.E., Means A.R., Witters L.A. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 2005, 280:29060-29066.
26. Stein S.C., Woods A., Jones N.A., Davison M.D., Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 2000, 345(Pt 3):437-443.
27. Riek U., Scholz R., Konarev P., Rufer A., Suter M., Nazabal A., Ringler P., Chami M., Muller S.A., Neumann D., Forstner M., Hennig M., Zenobi R., Engel A., Svergun D., Schlattner U., Wallimann T. Structural properties of AMP-activated protein kinase: dimerization, molecular shape, and changes upon ligand binding. J. Biol. Chem. 2008, 283:18331-18343.
28. Gao G., Fernandez C.S., Stapleton D., Auster A.S., Widmer J., Dyck J.R., Kemp B.E., Witters L.A. Non-catalytic beta- and gamma-subunit isoforms of the 5'-AMP-activated protein kinase. J. Biol. Chem. 1996, 271:8675-8681.
29. Woods A., Cheung P.C., Smith F.C., Davison M.D., Scott J., Beri R.K., Carling D. Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J. Biol. Chem. 1996, 271:10282-10290.
30. Scott J.W., Hawley S.A., Green K.A., Anis M., Stewart G., Scullion G.A., Norman D.G., Hardie D.G. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. 2004, 113:274-284.
31. Dasgupta B., Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl Acad. Sci. USA 2007, 104:7217-7222.
32. Ramamurthy S., Ronnett G.V. Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain. J. Physiol. 2006, 574:85-93.
33. Meley D., Bauvy C., Houben-Weerts J.H., Dubbelhuis P.F., Helmond M.T., Codogno P., Meijer A.J. AMP-activated protein kinase and the regulation of autophagic proteolysis. J. Biol. Chem. 2006, 281:34870-34879.
34. Terai K., Hiramoto Y., Masaki M., Sugiyama S., Kuroda T., Hori M., Kawase I., Hirota H. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol. Cell. Biol. 2005, 25:9554-9575.
35. Stapleton D., Mitchelhill K.I., Gao G., Widmer J., Michell B.J., Teh T., House C.M., Fernandez C.S., Cox T., Witters L.A., Kemp B.E. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 1996, 271:611-614.
36. Salt I., Celler J.W., Hawley S.A., Prescott A., Woods A., Carling D., Hardie D.G. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem. J. 1998, 334(Pt 1):177-187.
37. Shiyanov P., Nag A., Raychaudhuri P. Cullin 4A associates with the UV-damaged DNA-binding protein DDB. J. Biol. Chem. 1999, 274:35309-35312.
38. J.J. Higgins, A.L. Tal, X. Sun, S.C. Hauck, J. Hao, B.E. Kosofosky, A.M. Rajadhyaksha, Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence, J. Neurogenet. 24 18-26.
39. Barakat B.M., Wang Q.E., Han C., Milum K., Yin D.T., Zhao Q., Wani G., Arafa E.S., El-Mahdy M.A., Wani A.A. Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis. Int. J. Cancer 2009.
40. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., Stockinger B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
41. Lund A.K., Agbor L.N., Zhang N., Baker A., Zhao H., Fink G.D., Kanagy N.L., Walker M.K. Loss of the aryl hydrocarbon receptor induces hypoxemia, endothelin-1, and systemic hypertension at modest altitude. Hypertension 2008, 51:803-809.
42. Beck B.D., Park S.J., Lee Y.J., Roman Y., Hromas R.A., Lee S.H. Human Pso4 is a metnase (SETMAR)-binding partner that regulates metnase function in DNA repair. J. Biol. Chem. 2008, 283:9023-9030.
43. Garcia-Gil M., Pesi R., Perna S., Allegrini S., Giannecchini M., Camici M., Tozzi M.G. 5'-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience 2003, 117:811-820.
44. Jung J.E., Lee J., Ha J., Kim S.S., Cho Y.H., Baik H.H., Kang I. 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells. Neurosci. Lett. 2004, 354:197-200.
45. Stahmann N., Woods A., Carling D., Heller R. Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. Mol. Cell. Biol. 2006, 26:5933-5945.